Home > Healthcare > Medical Devices > Diagnostic Devices > Point of Care Molecular Diagnostics Market

Point of Care Molecular Diagnostics Market Share

Report ID: GMI2210
Published Date: Jan 2023
Report Format: PDF

Download Free Sample

Point of Care Molecular Diagnostics Market Share

Some leading companies operating in the point of care molecular diagnostics market are

BioMerieux SA
Danaher Corporation
Bio-Rad Laboratories
Sysmex Corporation
Roche Diagnostics
OraSure Technologies, Inc
VIRCELL S.L.

Several new advancements and product range expansion efforts by industry players are estimated to be observed in the market. In July 2022, OraSure Technologies, Inc., a global leader in point of care diagnostic testing technologies, announced the availability of the OMNIgene•GUT DNA and RNA product (OMR-205) to gut microbiome researchers, allowing them insight into gut microbes gene expression.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for point of care molecular diagnostics was worth more than USD 38.5 billion in 2022 and is set to grow significantly at over 8.5% CAGR through 2032 driven by the increasing efforts for advancing diagnostic procedures.

Oncology segment is forecast to expand at over 9.5% CAGR between 2023 and 2032 owing to the rising prevalence of cancer and increasing healthcare expenditure.

Europe point of care molecular diagnostics market is projected to surpass USD 23 billion in revenue by 2032 due to the proliferation of molecular technology across major European countries.

Some of the top firms operating in the point of care molecular diagnostics industry are BioMerieux SA, Danaher Corporation, Bio-Rad Laboratories, Sysmex Corporation, Abaxis Inc, Roche Diagnostics, OraSure Technologies, Inc., and VIRCELL S.L. among others.